343 related articles for article (PubMed ID: 30209243)
1. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Byrne LM; Rodrigues FB; Johnson EB; Wijeratne PA; De Vita E; Alexander DC; Palermo G; Czech C; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209243
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
Rodrigues FB; Byrne LM; Tortelli R; Johnson EB; Wijeratne PA; Arridge M; De Vita E; Ghazaleh N; Houghton R; Furby H; Alexander DC; Tabrizi SJ; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328328
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
[TBL] [Abstract][Full Text] [Related]
4. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Wild EJ; Boggio R; Langbehn D; Robertson N; Haider S; Miller JR; Zetterberg H; Leavitt BR; Kuhn R; Tabrizi SJ; Macdonald D; Weiss A
J Clin Invest; 2015 May; 125(5):1979-86. PubMed ID: 25844897
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
[TBL] [Abstract][Full Text] [Related]
6. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
[TBL] [Abstract][Full Text] [Related]
7. Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
Niemelä V; Landtblom AM; Blennow K; Sundblom J
PLoS One; 2017; 12(2):e0172762. PubMed ID: 28241046
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.
Soylu-Kucharz R; Sandelius Å; Sjögren M; Blennow K; Wild EJ; Zetterberg H; Björkqvist M
Sci Rep; 2017 Oct; 7(1):14114. PubMed ID: 29074982
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
Morena E; Romano C; Marconi M; Diamant S; Buscarinu MC; Bellucci G; Romano S; Scarabino D; Salvetti M; Ristori G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047023
[TBL] [Abstract][Full Text] [Related]
10. Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression.
Parkin GM; Corey-Bloom J; Snell C; Castleton J; Thomas EA
Parkinsonism Relat Disord; 2021 Jun; 87():32-38. PubMed ID: 33940564
[TBL] [Abstract][Full Text] [Related]
11. Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay.
Fodale V; Boggio R; Daldin M; Cariulo C; Spiezia MC; Byrne LM; Leavitt BR; Wild EJ; Macdonald D; Weiss A; Bresciani A
J Huntingtons Dis; 2017; 6(4):349-361. PubMed ID: 29125493
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice.
Caron NS; Banos R; Aly AE; Xie Y; Ko S; Potluri N; Anderson C; Black HF; Anderson LM; Gordon B; Southwell AL; Hayden MR
Neurobiol Dis; 2022 May; 166():105652. PubMed ID: 35143966
[TBL] [Abstract][Full Text] [Related]
13. Salivary Huntingtin protein is uniquely associated with clinical features of Huntington's disease.
Parkin GM; Corey-Bloom J; Snell C; Smith H; Laurenza A; Daldin M; Bresciani A; Thomas EA
Sci Rep; 2023 Jan; 13(1):1034. PubMed ID: 36658243
[TBL] [Abstract][Full Text] [Related]
14. Disease-related Huntingtin seeding activities in cerebrospinal fluids of Huntington's disease patients.
Lee CYD; Wang N; Shen K; Stricos M; Langfelder P; Cheon KH; Cortés EP; Vinters HV; Vonsattel JP; Wexler NS; Damoiseaux R; Frydman J; Yang XW
Sci Rep; 2020 Nov; 10(1):20295. PubMed ID: 33219289
[TBL] [Abstract][Full Text] [Related]
15. Quantifying Huntingtin Protein in Human Cerebrospinal Fluid Using a Novel Polyglutamine Length-Independent Assay.
Fodale V; Pintauro R; Daldin M; Spiezia MC; Macdonald D; Bresciani A
J Huntingtons Dis; 2022; 11(3):291-305. PubMed ID: 35938256
[TBL] [Abstract][Full Text] [Related]
16. Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament light.
Parkin GM; Thomas EA; Corey-Bloom J
EBioMedicine; 2024 Jun; 104():105173. PubMed ID: 38815362
[TBL] [Abstract][Full Text] [Related]
17. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.
Weiss A; Träger U; Wild EJ; Grueninger S; Farmer R; Landles C; Scahill RI; Lahiri N; Haider S; Macdonald D; Frost C; Bates GP; Bilbe G; Kuhn R; Andre R; Tabrizi SJ
J Clin Invest; 2012 Oct; 122(10):3731-6. PubMed ID: 22996692
[TBL] [Abstract][Full Text] [Related]
18. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
20. Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease.
Sampedro F; Pérez-Pérez J; Martínez-Horta S; Pérez-González R; Horta-Barba A; Campolongo A; Izquierdo C; Pagonabarraga J; Gómez-Ansón B; Kulisevsky J
Parkinsonism Relat Disord; 2021 Apr; 85():91-94. PubMed ID: 33770670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]